Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
18 juil. 2023 08h00 HE
|
Predictive Oncology Inc.
Surrounded by world renowned universities and medical centers,Predictive Oncology is part of the next generation of Pittsburgh’s innovation ecosystem PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) --...
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
27 juin 2023 08h00 HE
|
Predictive Oncology Inc.
EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
20 juin 2023 08h00 HE
|
Predictive Oncology Inc.
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
23 mai 2023 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 23, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology, Inc. (NASDAQ: POAI) announced today that the company’s Chief Business Officer, Pamela Bush, Ph.D., MBA, will present at the...
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
15 mai 2023 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 15, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023
08 mai 2023 08h00 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
02 mai 2023 17h10 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 02, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Announces Reverse Stock Split
20 avr. 2023 17h10 HE
|
Predictive Oncology Inc.
Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023 EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the...
Predictive Oncology Adjourns Special Meeting of Stockholders
17 avr. 2023 18h00 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, April 17, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board
04 avr. 2023 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...